Sgromo, A Department Biochemistry, Max Planck Institute for Developmental Biology, Max Planck Society;
Spisni, E., Valerii, M., De Fazio, L., Cavazza, E., Borsetti, F., Sgromo, A., et al. (2015). Cyclooxygenase-2 silencing for the treatment of colitis: a combined in vivo strategy based on RNA interference and engineered Escherichia coli. Molecular Therapy, 23(2), 278-289. doi:10.1038/mt.2014.222.